Stay updated on VELIA Clinical Trial: Veliparib in Ovarian Cancer

Sign up to get notified when there's something new on the VELIA Clinical Trial: Veliparib in Ovarian Cancer page.
Latest website image capture
Clouds background image

Latest updates to the VELIA Clinical Trial: Veliparib in Ovarian Cancer page

  1. Check
    6 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page now displays the VELIA trial record—including its design, eligibility, outcomes, locations, publications, and data-sharing information—in place of an access-denied screen.
    Difference
    100%
    Check dated 2026-11-09T00:41:34.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site footer now identifies the release as v3.8.0 instead of v3.7.2; the study record remains inaccessible.
    Difference
    0.2%
    Check dated 2026-11-02T00:28:04.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    An NIH-wide notice about the terminology transition from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page.
    Difference
    1%
    Check dated 2026-10-26T00:40:10.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T00:45:29.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label updates from v3.7.0 to v3.7.1; the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T00:53:29.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The study record view displays a 403 Forbidden message and a Home link instead of study information.
    Difference
    0.5%
    Check dated 2026-10-05T00:34:11.000Z thumbnail image

Stay in the know with updates to VELIA Clinical Trial: Veliparib in Ovarian Cancer

Enter your email address, and we'll notify you when there's something new on the VELIA Clinical Trial: Veliparib in Ovarian Cancer page.